The page lists 59 projects related to the topic "antiviral".
# | |||
---|---|---|---|
1 | BLOODCELLSCROSSTALK | The Crosstalk Between Red And White Blood Cells: The Case Of Fish | 2015 |
2 | ANTIVIRALS | European Training Network on Antiviral Drug Development | 2015 |
3 | RegulRNA | Modulation of RNA-based regulatory processes by viruses | 2016 |
4 | InterAcTEV | Genome-wide analysis of RNA and protein interacting profiles during a plant virus infection | 2015 |
5 | DDRR | Dissecting dsRNA uptake in RNAi-based antiviral immunity | 2015 |
6 | LiVirIn | 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction | 2015 |
7 | ARENAVIRUS | Molecular mechanisms of arenavirus cell entry and antibody-mediated neutralization | 2015 |
8 | BRACE | Breaking down arenavirus cell entry | 2015 |
9 | virus-DNP-NMR | Development of high-field DNP-enhanced MAS NMR techniques for structure determination of viral capsids | 2015 |
10 | MAPP | Mosquito Antiviral piRNA Pathway | 2015 |
11 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
12 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
13 | D-FENS | Dicer-Dependent Defense in Mammals | 2015 |
14 | GENESIS | GENEtic DiSsection of Innate Immune Sensing and Signalling | 2015 |
15 | SENTINEL | HIV-1 sensing and signaling in dendritic cells | 2015 |
16 | RESTRIVIR | Characterization of a novel mechanism restricting virus infection in reproductive tissues | 2016 |
17 | CHIKV-FBDD | Structural investigation into functionality of Chikungunya virus nsP2 in replication complex and screening of small molecules for its inhibition | 2016 |
18 | STRAVIR | Role of the stroma-derived ‘alarmin’ IL-33 in anti-viral immunity | 2016 |
19 | VGAP | The Viral Genome Associated Proteome | 2017 |
20 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
21 | COV RESTRIC | Unravelling species barriers of coronaviruses | 2017 |
22 | PHOTORNA | Development of photoswitchable ligands for the reversible and selective assembly with RNA | 2017 |
23 | DCBIO | In vivo functions of nuclear envelope rupture and antiviral specialization in dendritic cells | 2018 |
24 | StressEBOV | Ebola virus manipulation of the cellular stress responses | 2017 |
25 | AcTaferon | Revitalizing the clinical potential of type I IFNs in fighting influenza A virus infections with AcTaferon. | 2017 |
26 | PATHORISC | Reprogramming of small RNA function in plant-pathogen interactions | 2017 |
27 | Vis-a-Vis | Collective Infectious Units and the Social Evolution of Viruses | 2017 |
28 | PALE-Blu | Understanding pathogen, livestock, environment interactions involving bluetongue virus | 2017 |
29 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
30 | NOVITREP | Novel viral therapy through targeting DNA repair | 2017 |
31 | ANTIViR | Molecular mechanisms of interferon-induced antiviral restriction and signalling | 2017 |
32 | FINDER | FINDER: FIghtiNg DEngue viRus, a novel strategy for the development of fully protective antiviralsthat act by disrupting the DENV NS3/NS5 interaction | 2018 |
33 | WolAntiS | Using antisense inhibition to understand Wolbachia symbiosis and antiviral protection | 2019 |
34 | rSAMs-NANO | Nanoparticles with switchable shells for virus sensing and inhibition | 2018 |
35 | SquaMem | Interaction of squalene-based anti-cancer and neuroprotective drugs with cell membranes: in silico study | 2018 |
36 | WOLBAKIAN | Functional genetics of Wolbachia proliferation and protection to viruses | 2018 |
37 | ENVISION | Novel mechanisms of early defense against virus infections | 2018 |
38 | HIPShot | HBV GenetIc and Proteomic Screen | 2019 |
39 | OrganoVIR | Organoids for Virus Research - An innovative training-ETN programme | 2019 |
40 | kINPen | Developing a high-innovative portable cold plasma device for efficient healing of chronic wounds in veterinary medicine | 2019 |
41 | ProDAP | Protein Dynamics in Antiviral Processes | 2019 |
42 | ImmunoStem | Dissecting and Overcoming Innate Immune Barriers for Therapeutically Efficient Hematopoietic Stem Cell Gene Engineering | 2019 |
43 | SUPRAVACC | Supramolecular engineering of glycan-decorated peptides as synthetic vaccines | 2019 |
44 | UncoveRNAi | Deciphering the mechanisms of antiviral RNA interference in mammals | 2019 |
45 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
46 | MetAeAvIm | The Role of the Metabolism in Mosquito Immunity against Dengue virus in Aedes aegypti | 2019 |
47 | FUSEDESIGN | Model-guided design of a stabilized pre-fusion class III viral fusogen, rabies virus glycoprotein | 2019 |
48 | MDR | Structural and functional characterization of MAVS-DDX3-vRNA complex | 2019 |
49 | INITIATE | INnate-ImmunomeTabolIsm as Antiviral TargEt | 2019 |
50 | DRmov | Deciphering the RBPome in mosquitoes during virus infection | 2020 |
51 | IMpaCT | Imaging life from Molecules to cells - building knowledge on Cryo-electron microscopy methodologies | 2019 |
52 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
53 | InflaCare | An exosome-based therapeutic approach against chronic inflammation | 2020 |
54 | DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES | 2020 |
55 | CHUbVi | Ubiquitin Chains in Viral Infections | 2020 |
56 | AntiViralEvo | Unravelling the evolution of antiviral sensors and response systems in animals using the phylum Cnidaria | 2020 |
57 | RNAVirFitness | The dark side of evolution: the deleterious mutational landscape of RNA viruses | 2020 |
58 | BatSECoV | Canonical and non-canonical secretory mechanisms of cytokines in bat and human cell cultures in response to coronavirus infection: a comparative study | 2021 |
59 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |